Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-11-26 Purchase | 2025-12-01 4:15 pm | JOHNSON & JOHNSON | JNJ | MORIKIS JOHN G Director | 1,250 | $206.15 | $257,688 | 1,849 (Direct) | View |
| 2025-11-26 Sale | 2025-12-01 4:07 pm | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 6,337 | $10.03 | $63,560 | 4,040,861 (Indirect) | View |
| 2025-11-21 Sale | 2025-11-25 12:54 pm | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 2,700 | $10.05 | $27,132 | 4,047,198 (Indirect) | View |
| 2025-11-12 Sale | 2025-11-14 3:07 pm | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 1,000 | $10 | $10,000 | 4,049,898 (Indirect) | View |
| 2025-11-06 Sale | 2025-11-10 3:28 pm | CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner | 52,532 | $10.21 | $536,310 | 4,050,898 (Indirect) | View |
| 2025-10-17 Sale | 2025-10-20 7:13 pm | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 21,721 | $192.71 | $4,185,793 | 54,100 (Direct) | View |
| 2025-09-04 Sale | 2025-09-05 6:00 pm | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 56,471 | $177.81 | $10,040,883 | 178,013 (Direct) | View |
| 2025-08-22 Sale | 2025-08-25 7:12 pm | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 125,824 | $179.21 | $22,548,655 | 407,793 (Indirect Direct) | View |
| 2025-08-15 Sale | 2025-08-18 6:19 pm | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 16,820 | $176.91 | $2,975,571 | 84,980 (Indirect Direct) | View |
| 2025-07-17 Sale | 2025-07-18 4:12 pm | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 19,137 | $163.55 | $3,129,830 | 10,658 (Direct) | View |
| 2024-04-30 Purchase | 2025-02-28 7:05 pm | JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director | 100 | $145.53 | $14,553 | 400 (Indirect) | View |
| 2025-02-25 Sale | 2025-02-26 6:42 pm | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 6,999 | $165.88 | $1,160,994 | 21,755 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-10-17 Exercise | 2025-10-20 7:13 pm | N/A 2034-02-15 | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 21,721 | $157.92 | 54,100 (Direct) | View |
Ownership | 2025-09-15 4:36 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | MORIKIS JOHN G Director | 0 | $0 | 599 (Direct) | View |
| 2025-09-09 Option Award | 2025-09-11 5:52 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director | 281 | $178.07 | 13,817 (Direct) | View |
| 2025-09-09 Option Award | 2025-09-11 5:48 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Pinto Daniel E Director | 175 | $178.07 | 175 (Direct) | View |
| 2025-09-09 Option Award | 2025-09-11 5:46 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director | 211 | $178.07 | 4,841 (Direct) | View |
| 2025-09-04 Exercise | 2025-09-05 6:00 pm | 2019-02-09 2026-02-08 | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 56,471 | $101.87 | 178,013 (Direct) | View |
| 2025-08-29 Exercise | 2025-09-03 5:13 pm | 2020-02-13 2027-02-13 | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 11,521 | $115.67 | 12,853 (Direct) | View |
| 2025-08-29 Tax Withholding | 2025-09-03 5:13 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel | 9,570 | $177.2 | 12,853 (Direct) | View |
| 2025-08-22 Exercise | 2025-08-25 7:12 pm | 2019-02-09 2026-02-08 | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 125,824 | $101.87 | 407,793 (Direct) | View |
| 2025-08-15 Exercise | 2025-08-18 6:19 pm | 2019-02-09 2026-02-08 | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 16,820 | $101.87 | 84,980 (Direct) | View |
Ownership | 2025-07-08 5:31 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Pinto Daniel E Director | 0 | $0 | 0 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 4:32 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director | 322 | $155.23 | 13,438 (Direct) | View |
| 2025-06-10 Option Award | 2025-06-12 4:30 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director | 231 | $155.23 | 4,597 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-05 5:10 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 25,255 | $0 | 55,050 (Direct) | View |
| 2025-05-01 Tax Withholding | 2025-05-05 5:10 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 11,002 | $156.31 | 55,050 (Direct) | View |
| 2025-04-24 Option Award | 2025-04-28 5:57 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director | 1,316 | $0 | 4,330 (Direct) | View |
| 2025-04-24 Option Award | 2025-04-28 5:54 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | West Nadja Director | 1,316 | $0 | 6,573 (Direct) | View |
| 2025-04-24 Option Award | 2025-04-28 5:52 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | WEINBERGER MARK A Director | 1,316 | $0 | 10,737 (Direct) | View |
| 2025-04-24 Option Award | 2025-04-28 5:50 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | McClellan Mark B. Director | 1,316 | $0 | 19,755 (Direct) | View |
| 2025-04-24 Option Award | 2025-04-28 5:48 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Joly Hubert Director | 1,316 | $0 | 7,987 (Direct) | View |
| 2025-04-24 Option Award | 2025-04-28 5:45 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Johnson Paula A Director | 1,316 | $0 | 4,266 (Direct) | View |
| 2025-04-24 Option Award | 2025-04-28 5:41 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director | 1,316 | $0 | 13,007 (Direct) | View |
| 2025-04-24 Option Award | 2025-04-28 5:39 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Beckerle Mary C Director | 1,316 | $0 | 15,395 (Direct) | View |
| 2025-04-24 Option Award | 2025-04-28 5:38 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Doudna Jennifer A Director | 1,316 | $0 | 9,656 (Direct) | View |
| 2025-03-18 Gift | 2025-03-19 8:07 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board | 130,852 | $0 | 407,782 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 4:42 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director | 226 | $166.1 | 11,691 (Direct) | View |
| 2025-03-04 Option Award | 2025-03-06 4:38 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director | 188 | $166.1 | 3,014 (Direct) | View |
Ownership | 2025-02-28 7:05 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director | 0 | $0 | 400 (Indirect) | View |
| 2025-02-25 Exercise | 2025-02-26 6:42 pm | 2019-02-09 2026-02-08 | JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller | 6,999 | $101.87 | 21,755 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:44 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO | 96,909 | $0 | 96,909 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:37 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer | 32,744 | $0 | 32,744 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:35 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine | 95,320 | $0 | 95,320 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:33 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO | 36,603 | $0 | 36,603 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:31 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech | 52,955 | $0 | 52,955 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:29 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D | 95,320 | $0 | 95,320 (Direct) | View |
| 2025-02-15 Option Award | 2025-02-19 5:27 pm | N/A 2035-02-15 | JOHNSON & JOHNSON | JNJ | Mulholland Kristen EVP, Chief HR Officer | 29,676 | $0 | 29,676 (Direct) | View |